China’s Sinopharm has applied for regulatory approval to launch a COVID-19 vaccine for public use, but nearly 1 million people have already taken experimental shots

The rush to access coronavirus shots from Chinese vaccine frontrunner Sinopharm is spurring fears that a black market is forming and booming.
( read original story …)